North America Artificial Blood Market By Product Type (Hemoglobin-Based Oxygen Carriers, Perflurocarbon-Based Products, Recombinant Factors, Synthetic Platelets, Plasma Expanders, Others), By Application (Traumatic Injuries, Blood Disorders, Anemia, Surgeries, Others), By Distribution Channel (Hospitals, Clinics, Blood Banks), and Geography

 

Purchase Option

$ 3000
$ 4400
$ 4600
$ 6900

North America Artificial Blood Market is expected to grow at a CAGR of x% during the forecast period 2022 to 2028. Artificial blood or synthetic blood and blood products are the alternatives to the blood transfusion to replace the blood. It fulfills and replicates the normal functions of the body. Artificial blood is infused in the traumatic injuries and other disease conditions for the transportation of carbon di oxide and oxygen across the body. Moreover, scientists are focusing on the development of artificial blood due to inadequate number of blood donors leads to shortage of blood. However, there are adverse effects associated with the artificial blood such as hemoglobin based blood substitute might increase the occurrence of heart attacks. Lower shelf-life and instability of artificial blood, Adverse effects associated with artificial blood substitutes and Stringent regulatory guidelines for product approval are restraints of North America Artificial Blood Market. This report presents market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Market to better equip clients with possible investment opportunities across the regions (Country Investment Hot-Spots) and market unmet needs. Key stakeholders of the market report include raw material suppliers, manufacturers, marketers, policymakers, and healthcare service providers, who are engaged in usage and advocacy of Artificial Blood products.

North America Artificial Blood Market Summary

Study Period

2023-29

Base Year

2022

CAGR

X%

Largest Market

N/A

Fastest Growing Market

N/A
Dynamics

Increase in the prevalence of anemia and other blood disorders, Rise in R&D for the innovation of newer products and Increase in healthcare expenditure and well developed healthcare infrastructure are driving North America Artificial Blood Market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

North America Artificial Blood Market Segmentation

Product Type
  • Hemoglobin-Based Oxygen Carriers
  • Perflurocarbon-Based Products
  • Recombinant Factors
  • Synthetic Platelets
  • Plasma Expanders
  • Others
Application
  • Traumatic Injuries
  • Blood Disorders
  • Anemia
  • Surgeries
  • Others
Distribution Channel
  • Hospitals
  • Clinics
  • Blood Banks

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • FluorO2 Therapeutics (U.S.)
  • Alpha Therapeutic Corp (Grifols S.A.) (U.S.)